Complementary Medicines Australia

Complementary Medicines Australia (CMA) is the peak industry body for the complementary medicines industry, representing members across the supply chain, including manufacturers, importers, exporters, raw material suppliers, wholesalers, distributors and retailers. CMA promotes appropriate industry regulation and advancement to ensure consumers have access to complementary medicines of the highest quality.

CMA is the principal reference point for members, the government, the media and consumers to communicate about issues relating to the complementary medicines industry. CMA is proud to work closely with the TGA and other Australian government agencies, such as Austrade and DFAT, to ensure a strong and sustainable industry.  It is CMA’s aim to improve public health and wellbeing through education and information on the use of complementary medicines, to support and enhance a robust complementary healthcare products industry, and to support the ethical and responsible promotion of complementary medicines.

http://www.cmaustralia.org.au

Complementary medicines: vitamins and minerals, nutritional supplements, herbal and homeopathic medicines, aromatherapy products, natural cosmetics using herbals and botanicals and traditional medicines.

澳大利亞保健品協(xié)會(huì)

澳大利亞保健品協(xié)會(huì)（CMA）是保健品產(chǎn)業(yè)的高峰組織，代表會(huì)員橫跨整個(gè)供應(yīng)鏈，包括制造商、進(jìn)口商、出口商、原材料供應(yīng)商、批發(fā)商、經(jīng)銷商和零售商。CMA通過嚴(yán)格的產(chǎn)業(yè)監(jiān)管確保消費(fèi)者使用的保健品達(dá)到**標(biāo)準(zhǔn)。

CMA是協(xié)會(huì)成員、政府、媒體和消費(fèi)者關(guān)于保健品行業(yè)相關(guān)問題的主要參考點(diǎn)和聯(lián)系機(jī)構(gòu)。CMA與TGA、澳大利亞貿(mào)易委員會(huì)、外交部和貿(mào)易部等澳大利亞政府機(jī)構(gòu)緊密合作，以確保行業(yè)健康、可持續(xù)發(fā)展。CMA的宗旨是通過向公眾傳播和教導(dǎo)保健品知識(shí)來提高促進(jìn)人們的健康與福祉；支持和鞏固保健品產(chǎn)業(yè)的穩(wěn)健發(fā)展；支持和促進(jìn)保健品要負(fù)責(zé)任地推廣并且符合論理性。

http://www.cmaustralia.org.au

補(bǔ)充醫(yī)藥產(chǎn)品：維生素和礦物質(zhì)、營(yíng)養(yǎng)補(bǔ)充劑、草本植物和順勢(shì)療法**、芳香療法產(chǎn)品和天然草本化妝品和**。

Australian Complementary Medicines Industry

The complementary medicines sector in Australia has evolved into a major world class industry that supports domestic manufacturing, jobs, research and exports. Consumers worldwide are increasingly turning to complementary medicines as part of a proactive approach to healthcare, becoming more confident in self-selection and willing to take preventive measures to support their health. The Australian industry has been a success story in recent years due to a growing international demand for our complementary medicine products, which are seen globally as safe, effective and of exceptional quality. 

In Australia, the regulation of complementary medicines falls within the remit of the Therapeutic Goods Administration (TGA), which has the responsibility of regulation of all therapeutic goods, including medicines and medical devices. Australia’s complementary medicines industry is proud to be backed by a regulatory regime that is regarded as one of the strongest in the world.

The Therapeutic Goods Act 1989 (the Act), and the associated legislation, sets out the key elements of Australia’s regulatory scheme for therapeutic goods. The Act provides for a national system of controls relating to the quality, safety, efficacy, performance and timely availability of therapeutic goods used in Australia or exported from Australia. These controls are risk-based, with a two-tiered system for the regulation of all medicines, including complementary medicines.

There are over 12 000 complementary medicines available on the Australian market. These are included in the Australian Register of Therapeutic Goods (ARTG), which is a requirement for a therapeutic good to be lawfully supplied in Australia (a few complementary medicines are exempt from the requirement to be included on the ARTG, such as certain preparations of homoeopathic medicines). The vast majority of complementary medicines are in the lower risk listed category and there are approximately 140 products in the higher risk registered category.

Australia’s complementary medicines industry is backed by a regulatory regime that is regarded as one of the strongest in the world. Products are manufactured to a pharmaceutical standard under Good Manufacturing Practice (GMP), and strict safety and quality regulations are enforced by the TGA. 

澳大利亞保健品行業(yè)

澳大利亞保健品行業(yè)已經(jīng)發(fā)展成為支持國內(nèi)制造業(yè)、就業(yè)、科研和出口的產(chǎn)業(yè)。世界各地消費(fèi)者越來越多地將輔助醫(yī)藥產(chǎn)品作為積極主動(dòng)的保健方式，他們更加自信地選擇保健品來預(yù)防疾病并支持他們的健康。近年來，隨著世界各地消費(fèi)者對(duì)保健品需求的增加及對(duì)澳大利亞安全、有效、優(yōu)質(zhì)保健品的青睞，保健品行業(yè)已經(jīng)成為澳大利亞產(chǎn)業(yè)的成功典范。

在澳大利亞，保健品行業(yè)非常自豪地接受澳大利亞**管理局（TGA）的監(jiān)管。TGA被公認(rèn)為世界上**嚴(yán)格的監(jiān)管機(jī)構(gòu)，對(duì)藥品和醫(yī)療儀器等**性產(chǎn)品進(jìn)行監(jiān)管。

**品法案和相關(guān)法規(guī)為澳大利亞**品設(shè)定了監(jiān)管準(zhǔn)則。該法案為澳大利亞及其出口**品的質(zhì)量、安全、功效、性能和及時(shí)可用性設(shè)立了一套國家管制系統(tǒng)。這些管制措施以風(fēng)險(xiǎn)為基礎(chǔ)，是一套為包括保健品在內(nèi)所有藥品提供監(jiān)管的雙層系統(tǒng)。

澳大利亞市場(chǎng)有超過12000種輔助醫(yī)藥產(chǎn)品。為了符合澳大利亞**品合法供應(yīng)的要求，這些產(chǎn)品會(huì)進(jìn)行澳大利亞**品登記（ARTG）。（少數(shù)保健品不需要被ARTG要求進(jìn)行登記，例如一些順勢(shì)療法**的配制品。）大多數(shù)保健品歸屬于低風(fēng)險(xiǎn)類別，而有140種產(chǎn)品歸屬于高風(fēng)險(xiǎn)類別。

澳大利亞保健品行業(yè)由世界**嚴(yán)格的監(jiān)管制度把關(guān)。按“生產(chǎn)質(zhì)量管理規(guī)范”（GMP）的要求，保健品的生產(chǎn)需要達(dá)到制藥標(biāo)準(zhǔn)，同時(shí)還要符合 “澳大利亞**管理局”（TGA）嚴(yán)格的質(zhì)量安全標(biāo)準(zhǔn)。